The role of Raf-1 kinase in diabetic retinopathy

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.4, 2011-04, pp. : 357-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of growth factors in the pathogenesis of diabetic retinopathy

By Grant Maria B Afzal Aqeela Spoerri Polyxenie Pan Hao Shaw Lynn C Mames Robert N

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1275-1293

Informa Healthcare

Access to resources Recommend Favorite

Protein Kinase C Inhibitors in the Treatment of Diabetic Retinopathy. Review

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 386-391

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Targeting of Protein Kinase C Receptor: Promising Route for Diabetic Retinopathy?

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 405-413

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Discovery of Small Molecules Targeting Raf-1 Kinase

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2269-2278

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Growth Hormone, Insulin-Like Growth Factor and Somatostatin in Diabetic Retinopathy

Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. : 3307-3317

Bentham Science Publishers

Access to resources Recommend Favorite